Brief: Ultimovacs Implements Operational Adjustments To Support Continuous Advancement Of The Uv1 Vaccine Phase Ii Program

Zelluna ASA

16/04/2024 21:14

April 16 (Reuters) - Ultimovacs ASA  ULTI.OL :
    * REG- ULTIMOVACS IMPLEMENTS OPERATIONAL ADJUSTMENTS TO
SUPPORT
CONTINUOUS ADVANCEMENT OF THE UV1 VACCINE PHASE II PROGRAM
    * WORKFORCE REDUCTION OF APPROXIMATELY 40%
    * BASED ON CURRENT PLANS AND FORECASTS, CASH BURN RATE IS
ESTIMATED TO BE APPROXIMATELY NOK 15 MILLION PER QUARTER TOWARDS
END OF 2025
    * OPERATIONAL ADJUSTMENT PLAN EXTENDS ANTICIPATED CASH
RUNWAY TO
Q4 OF 2025

Source text for Eikon:  ID:nGNE3vDp44 
Further company coverage:  ULTI.OL 

 ((Reuters.Briefs@thomsonreuters.com;))